Feedback / Questions
Versamune HPV - PDS Biotech
https://www.globenewswire.com/news-release/2025/08/25/3138462/37149/en/PDS-Biotech-Announces-Final-Topline-Survival-Data-from-VERSATILE-002-Phase-2-Trial-in-Head-and-Neck-Cancer.html
Aug 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next